AOX BIOPHARMA Trademark

Trademark Overview

On Friday, February 25, 2022, a trademark application was filed for AOX BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the AOX BIOPHARMA trademark a serial number of 97284711. The federal status of this trademark filing is NOTICE OF ALLOWANCE - WITHDRAWN as of Thursday, January 16, 2025. This trademark is owned by AOX BIOPHARMA LLC. The AOX BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Scientific research and development; Scientific research in the field of preparations and substances for the treatment of skin
aox biopharma

General Information

Serial Number97284711
Word MarkAOX BIOPHARMA
Filing DateFriday, February 25, 2022
Status689 - NOTICE OF ALLOWANCE - WITHDRAWN
Status DateThursday, January 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements

NOT AVAILABLE"BIOPHARMA"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Scientific research and development; Scientific research in the field of preparations and substances for the treatment of skin

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAOX BIOPHARMA LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressST. CHARLES, IL 60174
Party NameAOX BIOPHARMA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressST. CHARLES, IL 60174

Trademark Events

Event DateEvent Description
Tuesday, March 1, 2022NEW APPLICATION ENTERED
Wednesday, March 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 9, 2022ASSIGNED TO EXAMINER
Thursday, December 15, 2022NON-FINAL ACTION WRITTEN
Thursday, December 15, 2022NON-FINAL ACTION E-MAILED
Thursday, December 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 11, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, July 11, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 26, 2023FINAL REFUSAL WRITTEN
Thursday, October 26, 2023FINAL REFUSAL E-MAILED
Thursday, October 26, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 25, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, January 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 9, 2024SUSPENSION LETTER WRITTEN
Friday, February 9, 2024LETTER OF SUSPENSION E-MAILED
Friday, February 9, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 16, 2025WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
Saturday, February 22, 2025WITHDRAWAL OF ATTORNEY GRANTED
Saturday, February 22, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Related Keywords

biopharma development research pharmaceutical preparations scientific treatment skin substances field medicines